Inamed Research GmbH & Co. KG

Gauting, Germany
Research institute in Gauting, Bavaria
Robert-Koch-Allee 29, 82131 Gauting

About Inamed Research GmbH & Co. KG


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
8
Chiesi Farmaceutici S.p.A.
1
Pari Pharma GmbH
1
Sterna Biologicals GmbH & Co. KG
1
Verona Pharma plc
1
Total Rows: 5

Clinical Trials at Inamed Research GmbH & Co. KG


During the past decade, Inamed Research GmbH & Co. KG conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11220000Started TrialsCompleted Trails201620170123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD)
2003-07-01
2005-10-01
Completed
250
Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of Asthma
2004-12-01
2006-04-01
Completed
472
Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)
2005-09-01
2005-12-01
Completed
19
A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)
2003-11-01
2004-09-01
Completed
605
12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD
2002-11-01
Completed
429
Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique.
2006-01-01
2006-02-01
Completed
13
Lung Deposition of the BDP/Formoterol Combination Administered Via the NEXT DPI in Healthy, Asthmatic and COPD Patients
2010-08-01
2010-10-01
Completed
28
Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)
2012-12-01
2013-12-01
Completed
38

Rows per page:

1–12 of 12

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Inamed Research GmbH & Co. KG" #1 sponsor was "Boehringer Ingelheim" with 8 trials, followed by "Chiesi Farmaceutici S.p.A." with 1 trials sponsored, "Pari Pharma GmbH" with 1 trials sponsored, "Sterna Biologicals GmbH & Co. KG" with 1 trials sponsored and "Verona Pharma plc" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 8Boehringer Ingelheim: 8Chiesi Farmaceutici S.p.A.: 1Chiesi Farmaceutici S.p.A.: 1Pari Pharma GmbH: 1Pari Pharma GmbH: 1Sterna BiologicalsGmbH & Co. KG: 1Sterna BiologicalsGmbH & Co. KG: 1Verona Pharma plc: 1Verona Pharma plc: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Inamed Research GmbH & Co. KG


According to Clinical.Site data, the most researched conditions in "Inamed Research GmbH & Co. KG" are "Pulmonary Disease, Chronic Obstructive" (8 trials), "Asthma" (5 trials), "COPD" (1 trials), "Cystic Fibrosis" (1 trials) and "Diabetic Nephropathies" (1 trials). Many other conditions were trialed in "Inamed Research GmbH & Co. KG" in a lesser frequency.

Clinical Trials Intervention Types at Inamed Research GmbH & Co. KG


Most popular intervention types in "Inamed Research GmbH & Co. KG" are "Drug" (9 trials) and "Device" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Berodual HFA-MDI" (2 trials), "Berodual Respimat" (2 trials), "10 mcg once daily tiotropium inhalation solution delivered by the Respimat inhaler" (1 trials) and "5 mcg once daily tiotropium inhalation solution delivered by the Respimat inhaler" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Inamed Research GmbH & Co. KG


The vast majority of trials in "Inamed Research GmbH & Co. KG" are 11 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Inamed Research GmbH & Co. KG


Currently, there are NaN active trials in "Inamed Research GmbH & Co. KG". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Inamed Research GmbH & Co. KG, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Inamed Research GmbH & Co. KG, 4 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 1: 4Phase 1: 4Phase 4: 4Phase 4: 4Phase 2: 3Phase 2: 3Phase 3: 2Phase 3: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 12Completed: 12